Tal Levi

The National Institute for Biotechnology in the Negev Ltd. is a research Institute that serves as an accelerator for technologies originating from Ben-Gurion University of the Negev, and located in the University campus. The institute's goal is to promote applied, innovative and groundbreaking research in the field of biotechnology, while leading the proof of scientific concept and commercialization. The research at the Institute focuses on areas that are at the forefront of the development of the pharma industry: Cancer, Degenerative diseases, Autoimmune and Metabolic diseases, Infectious diseases, Genetic diseases, as well as, applied Biotechnological research in the fields of AgBio. The research at the Institute has yielded over 900 publications in leading scientific journals, more than 60 patent families and a number of commercializations, mainly, licensing breakthrough technologies to third parties for further development and as a basis for establishing new startups.